Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer’s

The findings demonstrate how the brain’s memory centre operates at a ‘watershed’ making it especially vulnerable to damage Study suggests increasing blood flow in the hippocampus might be really effective at preventing...

HELP AT HAND FOR ORGANISATIONS SEEKING TO BUILD CLIMATE CHANGE RESILIENCE

An international authority on mitigating the effects of climate change, Climate Sense has joined forces with Learning & Development Associates (L&DA), a leading training provider to the UK water sector, to roll out the...

How NHS Wales streamlined sterile manufacturing to increase CCU capacity for second COVID-19 wave

Connect 2 Cleanrooms (C2C) expedited the design and build of a temporary medicines unit for NHS Wales’ new Central Intravenous Additive Service (CIVAS). In March during the first COVID-19 surge, the UK Government increased Critical...

What makes a spinout?

Universities carry out research into some of the most fundamental questions about life and the world around us, with researchers utilising specialist facilities and equipment to investigate and advance human knowledge.  This doesn’t happen overnight,...

Covid-19 transmission chains in the UK traced through time and space with remarkable accuracy...

A team of scientists, led by researchers from the Universities of Oxford and Edinburgh, has analysed the first wave of the Covid-19 outbreak in the UK and produced the most fine-scaled and comprehensive genomic...

Pioneering technique paves way for fast and cheap fabrication of rapid medical diagnostic tools

Breakthrough promises to democratise microfluidics and lab-on-a-chip technology, benefiting resource-poor countries and settings. New technology developed by the University of Bristol has the potential to accelerate uptake and development of on-chip diagnostic techniques in parts...

UK Government invests £5m to develop ‘library’ of MRNA vaccines

CPI has received a £5 million investment to support the development of an mRNA ‘vaccine library’ as part of the Government’s vaccine support package announced in the Budget by the chancellor, Rishi Sunak. The vaccine...

Delivering real impact to the world of bioscience

Since it opened in 2019, the National Horizons Centre has quickly established itself as a vital linchpin helping drive forward the life sciences sector across the UK. Through research, partnerships and training , the National...

CRYONISS EARNS COVETED MHRA QUALITY MARK

Experts in biological sample, and medicinal product, storage and logistics management, CRYONISS offers a comprehensive storage service from ambient down to vapour phase liquid nitrogen. The Cheshire-based team has a wealth of experience in supporting...

COVID-19 TESTING SECTOR DEMAND SET TO CONTINUE AMID VACCINE ROLLOUT

Amid the continued high demand for testing and staggered vaccine rollout, the diagnostics industry, which was valued in 2020 at $17.2bn-$19.8bn, is set to rise further in 2021 The diagnostics sector will continue to see...

EXPANSION OF NETPARK OFFERS SCIENCE AND TECHNOLOGY COMPANIES ROOM FOR GROWTH

The North-East Technology Park in County Durham – or NETPark as it is known – provides science, technology and engineering companies with the type of world-class laboratory, clean room and office space they require...

Research shows coronavirus can survive on healthcare uniforms for three days

Viruses similar to the strain that causes Covid-19 can survive on clothing and transmit to other surfaces for up to 72 hours, scientists at De Montfort University Leicester (DMU) have warned. In a study looking...

Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery

University of Birmingham researchers are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs. The encounter complex is formed...

Automated drug discovery platform brings about paradigm change for research

Bringing a single new drug to market takes years of research and costs billions – with the COVID-19 pandemic highlighting even more how critical it is to accelerate this process. The high costs and...

Freedom to Operate – Understanding the Risks

There are many factors to be considered for a project developing a new product or process, but the ability to carry out commercial plans without infringing third party patent rights (freedom to operate, or...

Clinical trials for gene and cell therapies

In early 2020, the Cell and Gene Therapy Catapult (CGTC) reported that there were 127 ongoing trials in advanced therapy medicinal products (ATMP) in the UK. This represented 12 percent of trials globally, helping...